Search
for

    Products matching "safety data"

    Tracking 1 products like 99 Pyrilutamide solution from by companies like MinoxidilMax. View product »

    Learn

    5 / 25 results

      learn GT20029

      research compound made to degrade androgen receptors in scalp

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Follistatin

      glycoprotein that inhibits TGF-β and promotes hair growth by antagonizing activin

    Research

    5 / 1000+ results

    Community Join

    5 / 699 results
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 4 months ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

      community Why are more people not using RU58841

      in Product  14 upvotes 8 months ago
      People are not using RU58841 for hair loss because it's not FDA approved, lacks long-term safety data, and is difficult to obtain and verify. They prefer FDA-approved treatments like minoxidil, finasteride, ketoconazole shampoo, and microneedling.

      community For those that have used anti androgens what is your experience?

      in Research/Science  17 upvotes 8 months ago
      People discussed their experiences with anti-androgens for hair loss, mentioning side effects like chest pains with RU58841 and skepticism due to lack of safety data, while considering Fluridil as a potential addition to treatment. Some users expressed reluctance to use these chemicals.

      community Anageninc RU58841 is legit & my experience

      in Research/Science  6 upvotes 1 year ago
      The user experienced side effects from RU58841, including dry eyes and potential eyesight issues, and decided to stop using it. They confirmed the product's legitimacy but advised caution due to its experimental status and lack of safety data.